Apoptosis Ligand (Trail), Angonistic monoclonal antibodies to trail receptors and molecule trail receptor agonists are different from preclinical and pretty clinical trials as potential anti-cancer
Read MoreThe role of Micronas (MIRNAS / MIRS) in the government of the progression of cutaneous carcinoma (CSCC) was at the center of recent studies. However,
Read MoreThe deryosination / retyrosing cycle is the most common post-translational modification of α-tubulin. Interestingly, for plants, the only qualified candidates of potential counterparts TTL are
Read MoreBACKGROUNDsalivary gland carcinoma (SGCs) is a rare malignancy with unknown etiology. The purpose of this research is to identify genetic variants modifying the risk of
Read Morecognitive impairment is a common and disabling problem in Parkinson’s disease (PD). Identification of genetic variants that influence the presence or severity of cognitive deficits
Read Moreassociation (GWA) studies have identified 19 independent genome loci general risk for endometriosis. Most variants of GWA is non-coding and the gene responsible for the
Read MoreWe conduct exploratory biomarker study of a phase II clinical trial of eribulin plus gemcitabine (EG) versus paclitaxel plus gemcitabine (PG) in metastatic breast cancer
Read MoreWe conduct exploratory biomarker study of a phase II clinical trial of eribulin plus gemcitabine (EG) versus paclitaxel plus gemcitabine (PG) in metastatic breast cancer
Read More